SHL Telemedicine Ltd. (SWX:SHLTN)

Market Cap	37.54M
Revenue (ttm)	50.27M
Net Income (ttm)	-7.94M
Shares Out	16.39M
EPS (ttm)	-0.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,626
Average Volume	2,203
Open	2.290
Previous Close	2.290
Day's Range	2.290 - 2.320
52-Week Range	1.105 - 5.900
Beta	0.43
RSI	49.55
Earnings Date	Apr 24, 2025

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio’B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monito...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1986
• Employees: 583
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SHLTN

Financial Performance

In 2023, SHL Telemedicine's revenue was $57.08 million, a decrease of -3.26% compared to the previous year's $59.00 million. Losses were -$7.06 million, 9184.2% more than in 2022.

Financial numbers in USD